Shares of Revvity Inc. (NYSE:RVTY – Get Free Report) have been assigned an average recommendation of “Hold” from the fourteen ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and four have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $107.7273.
RVTY has been the subject of a number of recent research reports. Barclays boosted their price objective on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. Stifel Nicolaus cut their price objective on shares of Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Weiss Ratings downgraded shares of Revvity from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 13th. JPMorgan Chase & Co. cut their price objective on shares of Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a report on Wednesday, May 6th. Finally, Wall Street Zen downgraded shares of Revvity from a “buy” rating to a “hold” rating in a report on Saturday, April 18th.
Read Our Latest Stock Report on Revvity
Institutional Trading of Revvity
Revvity Stock Performance
Shares of RVTY stock opened at $99.90 on Wednesday. The company has a market capitalization of $11.14 billion, a price-to-earnings ratio of 47.80, a PEG ratio of 2.17 and a beta of 1.11. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The company has a 50-day simple moving average of $96.39 and a 200 day simple moving average of $97.53. Revvity has a 52 week low of $81.22 and a 52 week high of $118.30.
Revvity (NYSE:RVTY – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.02 by $0.04. The firm had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts predict that Revvity will post 5.25 earnings per share for the current year.
Revvity Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Friday, July 17th. Revvity’s dividend payout ratio is 13.40%.
Revvity Company Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Read More
- Five stocks we like better than Revvity
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
